The Life Science and healthcare sectors are experiencing rapid changes in both organizational, technological and professional skill set dimensions. The worlds ageing populations, shrinking drug portfolios, advancing technology, increasing regulatory complexity and growing demands for healthcare services will be dominating factors of the future. These changes must be met and handled in new, innovative ways.
Market forces are now accelerating the pace of change. It is essential for the Health care sector to continue to attract, acquire, develop and retain excellent leaders.
Both the municipal government levels as well as the specialist healthcare service have large digitalization programs that will also contribute in the future to the population being able to receive healthcare services at all levels. The biotechnology and pharmaceutical industries are undergoing expansions as well. New business models are bringing change for traditional organizations and at the same time creating exciting opportunities for new players. Companies have to address market pressure on their top lines, while continuing to deliver growth, profitability and expansion and keeping better, more cost-efficient patient outcomes, at the fore. This is all happening in the face of patent expiration, intensifying generic competition and ever-increasing regulatory complexity.
Over the past decade Amrop Norway has assisted in recruiting leaders for the Life Science and Health Care sector in Norway. These are governmental authorities in research and education as well as executives for all the regional healthcare authorities involving CEO positions and senior management. We have assisted in establishing boards of directors in both private and public sectors. For more than 35 years, Amrop Norway has built and maintained a broad network enabling us to rapidly identify the most relevant candidates, and we have strong relationships with market leaders in core segments such as:
Creating Cultures | An interview with Professor Mark Lowdell
Immunotherapy, a type of Cell and Gene Therapy, is a rapidly emerging field currently transitioning into mainstream pharmaceuticals. Mark is an academic and clinical scientist as well as co-founder of a number of businesses.
What Really Counts in Digital Leadership?
A new Digital Competency Model
Chapter 3: Culture. For a digital strategy to grow and flourish, it must be rooted in a working culture that is developed and exemplified by a progressive CIO.